CRDO

GVK Bio continues to see growth tailwinds for 2020 thanks to a ‘crescendo of factors’

China-US trade challenges has led to de-risking by pharma companies Frankfurt, 05/10/19: GVK Bio, the global Contract Research and Development Organisation…

5 years ago